Adverse events and laboratory changes in a real-world population of patients with hepatitis C and chronic kidney disease treated with sofosbuvir-based therapy.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Adverse reactions
- 18 Dec 2015 New trial record